The HIH call, which involved a nationwide health innovation competition is directed at companies who have an innovative product, solution or service that are at pre-commercial or late development phase with the potential to significantly impact Irish healthcare.
Community pharmacist and Company Director Garvan Lynch says, “Our service delivers patient remote monitoring, care intervention, prescription management, medicines data capture at scale, enabled by our product: a custom-built, fit-for purpose, enterprise class system operating as:
– a virtual assistant, ‘companion’ app with on-screen and voice assistance as a future option;
– ready to support management of the next pandemic incl. symptom checking, contact tracing via its configurable version.
“Our diabetes management system (minimum viable product) enables health professionals to monitor diabetes in large patient groups, prioritise and assist those patients at risk, communicate with specialists and emergency care. Each patient receives algorithmic ongoing care feedback, and is contacted if diabetes indicators are above / below normal thresholds.”
Garvan worked in collaboration with Kyriakos Hatzaras – a former Supervisor Imperial College, London, where Garvan completed his MBA, who is now based in Luxembourg as a systems engineer – and Granite Digital in Cork.
As a team, they have previously won selection to the Flag-Ship European Union Health Innovation fund: The Horizon 2020 Project, finishing in the top 10 of projects from over the 500 who started, from around the EU. As a finalist, they were invited to present in Oslo to an audience of academics and health companies in November of last year.
Garvan commented, “Being part of the EU Horizon Fund was a truly extraordinary experience. We are in a very select and lucky group of innovators, as getting on the Horizon project is not easy.
“We received assistance in progressing our Medical Device from Experts all over the EU as part of the Horizon project. We have almost completed our journey towards CE marking.
“We are delighted to have been successful with our application to the Health Innovation Hub, Ireland. We are now in our 5th year developing our diabetes medical device and hope to commercialise the device, with the help of the Health Innovation Hub, in the next 9 months.”
